Public company
Outlook Therapeutics, Inc.
OTLKCIK 0001649989
Price$0.45
1 year-63.7%
Disclosed transactions1
Buys / sells0 / 0
Max Insider Score9
Connections with evidence2
OTLK · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Lundquist Kevin MichaelChief Financial Officer | OTLKOutlook Therapeutics, Inc. Grant or award | A | — 500.0K sh |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Insider ofevidenceLundquist Kevin MichaelChief Financial Officer · Sep 2, 2026